Gus Bilirakis actually said...
I think the best way to do that is to ask the FDA or direct the FDA by legislation, or statute, or regulation changes, to allow that communication to go forward.
Context
Bilirakis emphasizes the need for better communication with the FDA regarding pharmaceutical information.
07/21/2014